SEC Filings TLDR

Steven K. Conine, an officer and director of Wayfair Inc., has reported significant securities transactions involving Class A shares. The transactions include both sales and acquisitions, with notable sales occurring between August and October 2025. The largest single sale was on August 13, 2025, where 199,473 shares w...

The filing details the securities transactions of Niraj Shah, an officer and director of Wayfair Inc., and the adoption of a plan for the sale of securities. Shah sold a significant amount of Class A shares over the past three months, with transactions totaling millions of dollars. The sales occurred in both his person...

Niraj Shah, an officer and director of Wayfair Inc., has reported significant sales of Class A shares over the past three months. The sales, totaling millions of dollars, were executed through various accounts, including the Shah Charitable Foundation. The largest single sale occurred on 08/13/2025, with 199,422 shares...

Steven K. Conine, an officer and director of Wayfair Inc., has reported the sale of 11,000 Class A shares on 10/28/2025, with an aggregate market value of $1,100,000.00. The shares were originally acquired on 01/01/2002 as part of the Founders Shares. Additionally, Conine has engaged in multiple transactions over the p...

Edward E. Guillet, a director of Waste Connections, Inc., plans to sell 9,000 shares of the company's common stock. The shares were acquired on June 12, 2016, through a merger/acquisition. The sale is scheduled to occur on October 28, 2025, with an aggregate market value of $1,573,020. The transaction is being facilita...

David L DeNinno, an officer of Westinghouse Air Brake Technologies Corporation, has exercised stock options for 2,100 shares of common stock on October 28, 2025. The transaction was executed at a market value of approximately $419,730.78. The shares were acquired from the issuer, and the transaction was facilitated by ...

Greg Zante, an officer of Viking Therapeutics, Inc., has filed a Form 144 notice indicating the planned sale of 6,185 common stock units acquired as Performance Stock Units. The securities were acquired on October 27, 2025, and the approximate sale date is set for October 28, 2025. The aggregate market value of the sec...

Marianna Mancini, an officer of Viking Therapeutics, Inc., has filed a Form 144 notice indicating the intent to sell 6,185 shares of common stock. The shares were acquired on October 27, 2025, as Performance Stock Units. The approximate sale date is set for October 28, 2025, with an aggregate market value of $216,491.7...

Brian Lian, an officer of Viking Therapeutics, Inc., has filed a Form 144 notice indicating the sale of 38,989 common stock units. These units were acquired as Performance Stock Units on October 27, 2025, and are scheduled to be sold on October 28, 2025. The aggregate market value of the securities to be sold is approx...

Alex Gusinov, an officer of Vicor Corporation, has filed a Form 144 notice indicating the planned sale of 4,019 shares of common stock. The shares were acquired through the exercise of stock options on various dates between June 2018 and September 2019. The aggregate market value of the shares to be sold is approximate...

Zmira Lavie, a director at Vicor Corporation, exercised stock options for 3,720 shares of common stock on October 28, 2025. The transaction was executed at a market value of $333,237.60. The shares were acquired from the issuer, and the payment was made in cash. This filing indicates that there were no securities sold ...

Martine Rothblatt, the Founder, Chairperson, and CEO of United Therapeutics Corp, has filed a notice of sale of common stock. The filing details the sale of 4,000 shares on October 28, 2025, with an aggregate market value of $1,661,555.20. Additionally, the filing includes a comprehensive list of sales transactions ove...

The filing reports that Eric M. Dube, an officer at Travere Therapeutics, Inc., exercised stock options for 92,872 shares of common stock on October 28, 2025. The stock options were originally granted on June 16, 2025. The transaction was executed through Fidelity Brokerage Services LLC, and the aggregate market value ...

Heerma Peter, an officer of Travere Therapeutics, Inc., has filed a Form 144 notice indicating the planned sale of 2,662 shares of common stock. The shares were acquired through restricted stock vesting on 10/01/2020 and 02/04/2021. The sale is expected to occur on 10/28/2025, with an aggregate market value of $79,860....

Eric Lefkofsky, an officer, director, and 10% stockholder of Tempus AI, Inc., has filed a Form 144 notice indicating his intention to sell 332,500 shares of Class A Common stock. The shares are held by Blue Media, LLC (266,000 shares) and Gray Media, LLC (66,500 shares), entities for which Mr. Lefkofsky is the sole man...

The filing details the securities transactions of Brady J. Stewart, a former officer of Tyson Foods, Inc. Stewart sold 31,903 Class A shares on October 28, 2025, with an aggregate market value of $1,656,694.08. Additionally, Stewart had previously sold 7,611 Class A shares on September 9, 2025, for $423,544.08. The fil...

The filing discloses transactions involving Michael Klein, an officer of Travelers Companies, Inc. On October 28, 2025, Klein was granted options for 8,572 shares of common stock, which were acquired on the same date. Additionally, it is noted that Klein sold 10,000 shares of common stock on August 4, 2025, with gross ...

Corey C Dufresne, an officer of Symbotic Inc., has filed a Form 144 to report the planned sale of 11,734 restricted stock units of common stock. The securities were acquired on October 23, 2025, and the sale is expected to occur around October 28, 2025. The aggregate market value of the securities to be sold is approxi...

Maria G Freve, an officer of Symbotic Inc., has filed a Form 144 notice indicating her intention to sell 662 shares of common stock acquired through Restricted Stock Units. The shares were acquired on October 23, 2025, and are planned to be sold around October 28, 2025, with an aggregate market value of $46,796.78. Add...

RA Capital Nexus Fund III, L.P., a 10% stockholder and director of Sionna Therapeutics, Inc., has filed a Form 144 with the SEC indicating the sale of 17,118 shares of common stock. The shares were acquired during the company's IPO on February 7, 2025, and were sold on October 28, 2025, for an aggregate market value of...

RA Capital Healthcare Fund LP, a director and 10% stockholder of Sionna Therapeutics, Inc., has filed a Form 144 indicating its intent to sell 3,624 shares of Sionna Therapeutics' common stock. The shares were acquired on February 2, 2022, through a private transaction. Additionally, RA Capital Healthcare Fund LP recen...

RA Capital Nexus Fund, L.P., a significant shareholder and director of Sionna Therapeutics, Inc., has filed a Form 144 notice indicating its intention to sell 31,392 common shares of Sionna Therapeutics. These shares were acquired on September 18, 2020, through a private transaction. The approximate sale date is set fo...

Blackwell Partners LLC - Series A has filed a Form 144 with the SEC, indicating the intent to sell 104,476 shares of Sionna Therapeutics, Inc. common stock. The shares were acquired on September 18, 2020, through a private transaction. The approximate sale date is set for October 28, 2025, with an aggregate market valu...

Charles R. Schwab, an officer and director of Schwab Charles Corp, has filed a notice of sale of 64,400 shares of common stock. The shares were acquired on March 31, 1987, through a leveraged buyout. The sale is scheduled to occur on October 28, 2025, with an aggregate market value of $6,053,600. Additionally, Schwab h...

The filing details significant stock transactions by Anthony John Wood, a director, officer, and 10% stockholder of Roku, Inc., through THE WOOD REVOCABLE TRUST U/A DTD 12/01/2017. On 10/28/2025, the trust exercised stock options to acquire 2,900 shares of common stock. Additionally, the trust sold a substantial amount...